Manon Brunet
YOU?
Author Swipe
View article: Pan-fibrotic gene expression signature in major chronic diseases by integrative bulk and single-cell transcriptomic analyses
Pan-fibrotic gene expression signature in major chronic diseases by integrative bulk and single-cell transcriptomic analyses Open
Background Fibrosis is a common pathological endpoint across multiple chronic diseases affecting organs, including the liver, kidney, and heart. Despite its prevalence and clinical burden, there are currently no robust validated molecular …
View article: #1299 The SGLT2 inhibitor canagliflozin, but not dapagliflozin or empagliflozin, ameliorates vascular calcification in a mouse model of nephrocalcinosis
#1299 The SGLT2 inhibitor canagliflozin, but not dapagliflozin or empagliflozin, ameliorates vascular calcification in a mouse model of nephrocalcinosis Open
Background and Aims Vascular calcification, defined as the abnormal deposition of minerals in blood vessels, is a major cardiovascular risk factor in patients with kidney failure. Sodium-glucose co-transporter 2 (SGLT2) inhibitors, commonl…
View article: Common Mouse Models of Chronic Kidney Disease are Not Associated with Cachexia
Common Mouse Models of Chronic Kidney Disease are Not Associated with Cachexia Open
View article: Publisher Correction to: A universal predictive and mechanistic urinary peptide signature in acute kidney injury
Publisher Correction to: A universal predictive and mechanistic urinary peptide signature in acute kidney injury Open